As of 9:30 AM on the 1st, Alteogen is trading at 265,000 KRW, down 0.56% from the previous day. This is a 36.67% increase compared to June 3. Alteogen is known as a biosimilar developer.
Over the past 5 days, individual investors have net purchased 2,138 shares, while foreigners and institutions have net purchased 122,284 shares and net sold 117,019 shares, respectively.
On June 25, Alteogen became a market issue with the headline "Strong performance with 4.7 trillion KRW technology export to top 10 pharmaceutical companies."

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![User Who Sold Erroneously Deposited Bitcoins to Repay Debt and Fund Entertainment... What Did the Supreme Court Decide in 2021? [Legal Issue Check]](https://cwcontent.asiae.co.kr/asiaresize/183/2026020910431234020_1770601391.png)
